A rare opportunity Corrections in the stock market are fairly commonplace. But a full-blown market crash is far rarer. In fact, over the last 20 years, investors have only endured two of them ...

Nvidia stock has jumped above $150 and a new record in recent days, as investors shrug off concerns they had just a couple of months ago.

I’m under no illusion that some long-term investors in Palantir stock will be considering an early retirement. The stock has surged. When investing, your capital is at risk. The value of your ...

This UK growth stock has doubled in 2024 thanks in part to a lucrative US deal. With strong margins and a clean balance sheet, it could be an opportunity. When investing, your capital is at risk. The ...

These stocks looked like the only ones worth buying. And I’ve seen more than one fund manager that underperformed in 2024 put this down to not owning Nvidia shares. In 2025, though, things have ...

With his Diageo shares close to a 10-year low, Mark Hartley ponders whether it’s time to say goodbye to this major FTSE 100 dividend stock. When investing, your capital is at risk. The value of ...

2025’s been a rollercoaster ride for many US stocks, but the Apple (NASDAQ:AAPL) share price certainly appears to have a case of whiplash. As tariff announcements emerged, the business seemed to ...

How to invest in defence stocks Here are five things to think about before investing in defence shares: The outlook for defence spending Defence companies sell their products and services to ...

From those angles, the Lloyds share price could be a winner when considering the broader FTSE 100. This is because other FTSE 100 peers are international companies, with operations in China and ...

Jon Smith tots up the combined results for the highest-yielding stocks in the FTSE250 index and explains how it can become a second income source.

More broadly, the company’s long-term potential is a big plus for investors. The company aims to deliver $80bn in total revenue by the end of the decade, up from $54bn, driving improved earnings ...

AstraZeneca ’s (LSE: AZN) share price is down 28% from its 3 September 12-month traded high of £133.38. At that point, this made the firm the first in the UK with a market capitalisation of £ ...